摘要
目的 了解淋病及非淋菌性尿道炎(NGU)患者病原微生物感染状况及药物疗效情况.方法 分析了200例淋病及NGU患者的病原学状况,并对几种药物治疗及NGU的疗效进行了观察.结果 单纯淋球菌感染者34例(17%),解脲支原体感染为39例(19．5%),衣原体为65例(32．5%),混合性感染为53例(26．5%),念珠菌感染为9例(4．5%).淋病患者经头孢三嗪治疗后,淋球菌的转阴率明显高于淋必治(P＜0．01).NGU患者经阿奇霉素治疗后的转阴率略高于罗红霉素(P＞0．05).结论 NGU的发病率正以较快的速度上升.青霉素、淋必治的耐药率正在逐渐升高.
objective To study infective conditions of Pathogenic microorganism and pharmacotherapic effect in the patients with gonorrhea and non－gonococcal urethritis NGU． Methods Pathogenic microorganism in patients with gonorrhea and NGU were separated and identified by culcure and direct immunofluorescence． Curative effect of some drugs to gonorrhea and NGU were comparatively analyzed． Results There were 34 patients infected singl by Neisseria gonorrhea 39 by ureaplasma urelyticum UU 65 by chlamyclia trachomatis CT 9 by candida 53 by combining bacteria in 200 cases Their positive rates were 17% 19．5% 32．5% 26．5% and 4．5% respectively． Treated with ceffriaxone and spectinomycin the former＇s rate of transforming Nesseria gonorrhoeae into negative was markedly increased than later＇s P＜0．01． NGU patients treated with Azithromycin and Roxithromycin the former＇s effectiveness was somewhat good P＞0．05． Conclusion The morbidity of NGU is increaing quickly． Resistance rates of Penicillin and spectinomycin are raising gradually．
出处
《江西医药》
CAS
2000年第5期261-263,共3页
Jiangxi Medical Journal
关键词
淋病
药物疗法
非淋菌性尿道炎
微生物学
治疗
gonorrhea／drug therapy non－gonococcal urethritis／drug therapy gonorrhea／microbiology non－gonococcal urethritis／microbiology antibiotics／therapecctic use
